Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity

Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity

Raf kinase inhibitory protein (RKIP) functions as a chemo-immunotherapeutic sensitizer of cancers, but regulation of RKIP on tumor radiosensitivity remains largely unexplored. In this study, we investigate the role and mechanism of RKIP in nasopharyngeal carcinoma (NPC) radioresistance. The results...

Full description

Bibliographic Details
Main Authors: Yuan, Li, Yi, Hong-Mei, Yi, Hong, Qu, Jia-Quan, Zhu, Jin-Feng, Li, Li-Na, Xiao, Ta, Zheng, Zhen, Lu, Shan-Shan, Xiao, Zhi-Qiang
Format: Online
Language:English
Published: Impact Journals LLC 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905486/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905486/

Similar Items